The Europe disposable endoscopes market size is estimated to reach USD 1.21 billion by 2030, registering a CAGR of 7.73% from 2025 to 2030. The increasing cases of cross-contamination complications due to the use of reusable endoscopes are driving the adoption of single-use endoscopic devices. In addition, the growing number of chronic and respiratory diseases in Europe and the shortage of medical staff for cleaning and disinfecting reusable endoscopes in between the surgical procedures drive the market for disposable endoscopes. For instance, a study published in the European Respiratory journal in 2021 stated that about 36.6 million Europeans are having COPD and the number will be increased to 49.5 million by 2050. Furthermore, the risk associated with reusable endoscopes such as clogging, leakage, and the chance of contamination due to the tedious sterilization process is further expected to boost the market growth during the forecast period.
Reusable endoscopes are the potential source of disease transmission. While the disposable bronchoscope could decrease the risk of cross-contamination, increase safety and efficiency, and can be used with limited resources. In addition, increasing recommendations by most respiratory societies to use disposable bronchoscopes during the SARS-CoV-2 pandemic is accelerating the growth of the segment. Moreover, the ENT endoscopy segment is expected to witness the fastest growth during the forecast period owing to the high preference for the use of disposable endoscopic devices to limit the chances of infection during the ear, nose, and throat diagnostic procedures.
The hospitals end-use segment is expected to register a significant growth over the forecast period. This is attributed to the increasing patient preference for hospitals to diagnose and treat their chronic diseases. In addition, favorable reimbursement policies and low-cost surgical procedures provided by the government hospitals are expected to boost the segment growth. Moreover, the increasing adoption of disposable endoscopic devices and the growing number of private and government hospitals with endoscopic procedure facilities are supporting the growth of the segment. The clinics segment is anticipated to expand at the fastest CAGR during the forecast period owing to the increasing adoption of single-use endoscopes in clinics for better patient engagement with low cross-contamination chances, quick recovery time, and lower post-procedural complications.
Furthermore, the rapid rise of COVID-19 cases in Europe has limited the number of surgical procedures. However, due to the benefits of disposable endoscopes such as lower chances of cross-contamination, time efficiency, safety, short hospital stay, and lower post-procedure infections, many endoscopic procedure facilities have increasingly adopted the single-use endoscopic devices during the COVID-19 pandemic, which favored the growth of the market in 2020. The shortage of clinical personnel due to the viral infections and government-imposed lockdown and shutdowns further decreased the use of conventional endoscopes and in turn, increased the adoption of disposable endoscopic devices, thereby propelling the market growth during the COVID-19 pandemic.
This product will be delivered within 2 business days.
Reusable endoscopes are the potential source of disease transmission. While the disposable bronchoscope could decrease the risk of cross-contamination, increase safety and efficiency, and can be used with limited resources. In addition, increasing recommendations by most respiratory societies to use disposable bronchoscopes during the SARS-CoV-2 pandemic is accelerating the growth of the segment. Moreover, the ENT endoscopy segment is expected to witness the fastest growth during the forecast period owing to the high preference for the use of disposable endoscopic devices to limit the chances of infection during the ear, nose, and throat diagnostic procedures.
The hospitals end-use segment is expected to register a significant growth over the forecast period. This is attributed to the increasing patient preference for hospitals to diagnose and treat their chronic diseases. In addition, favorable reimbursement policies and low-cost surgical procedures provided by the government hospitals are expected to boost the segment growth. Moreover, the increasing adoption of disposable endoscopic devices and the growing number of private and government hospitals with endoscopic procedure facilities are supporting the growth of the segment. The clinics segment is anticipated to expand at the fastest CAGR during the forecast period owing to the increasing adoption of single-use endoscopes in clinics for better patient engagement with low cross-contamination chances, quick recovery time, and lower post-procedural complications.
Furthermore, the rapid rise of COVID-19 cases in Europe has limited the number of surgical procedures. However, due to the benefits of disposable endoscopes such as lower chances of cross-contamination, time efficiency, safety, short hospital stay, and lower post-procedure infections, many endoscopic procedure facilities have increasingly adopted the single-use endoscopic devices during the COVID-19 pandemic, which favored the growth of the market in 2020. The shortage of clinical personnel due to the viral infections and government-imposed lockdown and shutdowns further decreased the use of conventional endoscopes and in turn, increased the adoption of disposable endoscopic devices, thereby propelling the market growth during the COVID-19 pandemic.
Europe Disposable Endoscopes Market Report Highlights
- The market growth in Europe can be attributed to the growing number of chronic and respiratory diseases, the shortage of medical staff, and the increasing adoption of single-use endoscopic devices in healthcare institutions in the region
- The Laparoscopes segment is anticipated to witness the fastest CAGR over the forecast period, due to growing prevalence of chronic diseases and conditions that require surgical intervention, such as obesity, appendicitis, gallbladder diseases, pelvic inflammatory disease, and cancers
- Based on end-use, the hospitals segment is anticipated to reister significant growth, owing to the increasing adoption of disposable endoscopic devices and the growing number of private and government hospitals with endoscopic procedure facilities.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
- Competitive Landscape: Explore the market presence of key players worldwide
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
The leading players in the Europe Disposable Endoscopes market include:
- Olympus Corporation
- Boston Scientific Corporation
- PENTAX Medical (Hoya Corporation)
- FUJIFILM Holdings Corporation
- Karl Storz GmbH & Co., KG
- Stryker
- Medtronic
- Ambu A/S
- STERIS plc.
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Europe Disposable Endoscopes Market Variables, Trends & Scope
Chapter 4. Europe Disposable Endoscopes Market Segment Analysis, By Type, 2018-2030 (USD Million)
Chapter 5. Europe Disposable Endoscopes Market Segment Analysis, By End Use, 2018-2030 (USD Million)
Chapter 6. Region, By Product, By End Use, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Olympus Corporation
- Boston Scientific Corporation
- PENTAX Medical (Hoya Corporation)
- FUJIFILM Holdings Corporation
- Karl Storz GmbH & Co., KG
- Stryker
- Medtronic
- Ambu A/S
- STERIS plc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 777.2 Million |
| Forecasted Market Value ( USD | $ 1210 Million |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 9 |
